Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-08-24 Sale | 2021-08-26 8:05 pm | BioAtla Inc. | BCAB | Levy Guy Director | 546,709 | $39.65 | $21,677,012 | 862,788 (Indirect Direct) | View |
2021-06-17 Sale | 2021-06-21 4:30 pm | BioAtla Inc. | BCAB | Levy Guy Director | 400,000 | $39.16 | $15,664,000 | 1,340,981 (Indirect Direct) | View |
2020-12-18 Purchase | 2020-12-22 4:30 pm | BioAtla Inc. | BCAB | Levy Guy Director | 1,388,890 | $18 | $25,000,020 | 348,204 (Indirect Direct) | View |
2020-05-05 Purchase | 2020-05-15 6:16 pm | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 155,000 | $16 | $2,480,000 | 155,000 (Indirect) | View |
2020-05-05 Sale | 2020-05-15 6:16 pm | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 16,909 | $16 | $270,544 | 155,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-09-30 Option Award | 2021-09-30 8:00 pm | N/A N/A | BioAtla Inc. | BCAB | Levy Guy Director | 267,900 | $28 | 2,515,424 (Indirect) | View |
2021-06-15 Option Award | 2021-06-16 9:33 pm | N/A 2031-06-15 | BioAtla Inc. | BCAB | Levy Guy Director | 12,307 | $0 | 12,307 (Direct) | View |
2020-12-18 Conversion | 2020-12-22 4:30 pm | N/A N/A | BioAtla Inc. | BCAB | Levy Guy Director | 1,790,472 | $0 | 348,204 (Indirect) | View |
Ownership | 2020-12-15 8:00 pm | N/A N/A | BioAtla Inc. | BCAB | Levy Guy Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Director 10% Owner | 0 | $0 | 1,805,343 (Direct) | View |
2020-05-05 Exercise | 2020-05-15 6:16 pm | 2020-01-27 2030-01-27 | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 31,382 | $0 | 155,000 (Indirect) | View |
2020-05-05 Conversion | 2020-05-15 6:16 pm | N/A N/A | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 15,716,828 | $0 | 155,000 (Indirect) | View |
2020-05-05 Exercise | 2020-05-15 6:16 pm | N/A N/A | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 31,382 | $8.63 | 155,000 (Indirect) | View |
Ownership | 2020-05-15 6:13 pm | 2020-01-27 2030-01-27 | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Levy Guy 10% Owner | 0 | $0 | 31,382 (Indirect) | View |